ivosidenib
servier
['mds', 'servier']
we re proud to share updated results from our clinical development program in idh1-mutated relapsed or refractory myelodysplastic syndromes (mds) at this year s (eha) annual congress. read more about our latest oncology data: 
Servier Pharmaceuticals is a U.S. subsidiary of Servier with a focus on oncology treatment and care. See our community guidelines here: https://t.co/tHNeTw4iGH